PendingBRTH

ismagilov/iStock via Getty Images Canadian medtech Breathe BioMedical (BRTH) has disclosed terms for an $8M US initial public offering. Breathe said in an SEC filing that it was looking to offer 1.6M shares priced between $4 and $6 per share, which would raise $8M if priced at the midpoint. InContinue Reading